SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001114220-18-000050
Filing Date
2018-05-10
Accepted
2018-05-10 16:23:03
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kerx-3312018x10q.htm 10-Q 681519
2 EXHIBIT 10.1 kerx-3312018x10qex101.htm EX-10.1 160708
3 EXHIBIT 10.5 keryx-3312018x10qex105.htm EX-10.5 54355
4 EXHIBIT 31.1 kerx-3312018x10qex311.htm EX-31.1 13176
5 EXHIBIT 31.2 kerx-3312018x10qex312.htm EX-31.2 13082
6 EXHIBIT 32.1 kerx-3312018x10qex321.htm EX-32.1 6197
7 EXHIBIT 32.2 kerx-3312018x10qex322.htm EX-32.2 6232
  Complete submission text file 0001114220-18-000050.txt   3925735

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kerx-20180331.xml EX-101.INS 595870
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kerx-20180331.xsd EX-101.SCH 36438
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kerx-20180331_cal.xml EX-101.CAL 59760
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kerx-20180331_def.xml EX-101.DEF 148182
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kerx-20180331_lab.xml EX-101.LAB 461745
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kerx-20180331_pre.xml EX-101.PRE 266052
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 18822848
SIC: 2834 Pharmaceutical Preparations